Stay updated on Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site’s displayed revision number changed from v3.8.0 to v3.8.1.
    Difference
    0.0%
    Check dated 2026-11-19T11:23:02.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The site footer’s revision number changed from v3.7.2 to v3.8.0.
    Difference
    0.0%
    Check dated 2026-10-29T09:48:25.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    A site-wide NIH banner was added announcing a website transition and a change in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.2%
    Check dated 2026-10-22T08:46:44.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov version as v3.7.2 instead of v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-15T12:30:34.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-08T13:39:57.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    A new revision label v3.7.0 was added to the record history, replacing the previous v3.6.6 entry.
    Difference
    0.0%
    Check dated 2026-09-17T19:05:45.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page.